Cross border Collaboration: Australia China Pharmaceutical Association and Shenzhen Rennan Group Go to Australia to Promote Production Cooperation
Dr. Chen Jianchao, President of the Australian Traditional Chinese Medicine Chamber of Commerce, recently led representatives from the chamber and joined forces with members of the board of directors of Shenzhen Rennan Group, a strategic partner, to embark on a meaningful business exchange trip to Australia. This trip aims not only to deepen cross-border cooperation in the field of traditional Chinese medicine, but also to closely integrate practical exchanges and friendship, injecting new momentum into multi-party cooperation.
The first stop, the group headed to the headquarters of Homart Group, a well-known Australian company. During the communication with Chairman Ye Beiling of Homart Group, Dr. Chen Jianchao and members of Shenzhen Rennan Group, including Chairman Cai Mengshan and Vice Chairman Fu Zhenhui, engaged in in-depth discussions with the Homart Group team on core issues such as production collaboration models and potential areas of cooperation. From technical standards to market expansion, from resource integration to complementary advantages, the two sides reached many consensuses through frank communication. During the exchange, Dr. Chen Jianchao, on behalf of the Australian Traditional Chinese Medicine Association, expressed sincere gratitude to Homart Group Chairman Ye Beiling for her strong support in celebrating the establishment of the association. He stated that it was this deep friendship and tangible support across industries that brought the celebration of the establishment of the chamber of commerce to a successful conclusion, and also yielded fruitful results beyond expectations, laying a solid foundation for the start and development of the chamber of commerce. Homart Group is also looking forward to future cooperation among the three parties and hopes to use this exchange as an opportunity to further refine the cooperation path and achieve mutual benefit and win-win results.
After the exchange with Homart Group, the Australian Traditional Chinese Medicine Chamber of Commerce and Shenzhen Rennan Group rushed to OGS Pharmaceutical Factory in Australia. As a company with mature experience and advanced technology in the pharmaceutical field, OGS Pharmaceutical Factory's communication with visiting teams focuses on the production cooperation of Chinese herbal medicine. Both parties conducted detailed discussions on key aspects such as planting standards, extraction processes, quality control, and compliance certification of Chinese herbal medicine, and analyzed in depth the feasibility and specific path of combining high-quality Chinese herbal resources with modern pharmaceutical technology. The board members of Shenzhen Rennan Group have put forward several constructive cooperation ideas based on their practical experience in the industry chain. The Australian Traditional Chinese Medicine Chamber of Commerce has built a communication bridge for both parties from the perspective of industry development and resource integration, helping to explore more operational cooperation models. This exchange has given the three parties a clearer understanding of the production and market prospects of Chinese herbal medicine in Australia, and has also paved the way for substantive cooperation in the future.
During this trip to Australia, the Australian Chamber of Traditional Chinese Medicine, in collaboration with Shenzhen Rennan Group, not only strengthened their existing friendship through in-depth exchanges with Homart Group and OGS Pharmaceutical Factory, but also made positive progress in production and project cooperation. In the future, all parties will take this exchange as a new starting point, continue to promote pragmatic cooperation, and work together to contribute to the international development of traditional Chinese medicine.
